Axonics Inc (AXNX)
67.65
+0.37
(+0.55%)
USD |
NASDAQ |
May 06, 16:00
67.65
0.00 (0.00%)
After-Hours: 16:26
Axonics Cash from Financing (TTM): -5.062M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -5.062M |
December 31, 2023 | -3.38M |
September 30, 2023 | -3.797M |
June 30, 2023 | 127.21M |
March 31, 2023 | 134.45M |
December 31, 2022 | 133.97M |
September 30, 2022 | 134.01M |
June 30, 2022 | 3.649M |
March 31, 2022 | 115.74M |
December 31, 2021 | 170.51M |
September 30, 2021 | 171.37M |
Date | Value |
---|---|
June 30, 2021 | 171.14M |
March 31, 2021 | 200.06M |
December 31, 2020 | 144.19M |
September 30, 2020 | 253.63M |
June 30, 2020 | 252.44M |
March 31, 2020 | 111.26M |
December 31, 2019 | 110.96M |
September 30, 2019 | 136.04M |
June 30, 2019 | 135.94M |
March 31, 2019 | 135.63M |
December 31, 2018 | 165.34M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-5.062M
Minimum
Mar 2024
253.63M
Maximum
Sep 2020
124.72M
Average
134.23M
Median
Cash from Financing (TTM) Benchmarks
Boston Scientific Corp | 1.643B |
Cutera Inc | -2.568M |
Stereotaxis Inc | 0.081M |
Electromed Inc | -0.128M |
Myomo Inc | 9.714M |